SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094007
Filing Date
2024-08-08
Accepted
2024-08-08 16:15:39
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20240630.htm   iXBRL 10-Q 2556599
2 EX-10.2 vtyx-ex10_2.htm EX-10.2 41574
3 EX-31.1 vtyx-ex31_1.htm EX-31.1 17205
4 EX-31.2 vtyx-ex31_2.htm EX-31.2 17224
5 EX-32.1 vtyx-ex32_1.htm EX-32.1 9906
6 EX-32.2 vtyx-ex32_2.htm EX-32.2 9929
  Complete submission text file 0000950170-24-094007.txt   9388317

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vtyx-20240630.xsd EX-101.SCH 1117330
72 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20240630_htm.xml XML 1724551
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 241188572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)